NETHERTON NOW: BECAUSE EVERYONE DESERVES TO FEEL COMFORTABLE IN THEIR OWN SKIN Trademark
Trademark Overview
On Wednesday, November 13, 2024, a trademark application was filed for NETHERTON NOW: BECAUSE EVERYONE DESERVES TO FEEL COMFORTABLE IN THEIR OWN SKIN with the United States Patent and Trademark Office. The USPTO has given the NETHERTON NOW: BECAUSE EVERYONE DESERVES TO FEEL COMFORTABLE IN THEIR OWN SKIN trademark a serial number of 98850670. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, September 23, 2025. This trademark is owned by Quoin Pharmaceuticals, Inc.. The NETHERTON NOW: BECAUSE EVERYONE DESERVES TO FEEL COMFORTABLE IN THEIR OWN SKIN trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:
Pharmaceutical product and therapeutic pharmaceutical product for Netherton Syndrome, and rare and orphan skin diseases
Pharmaceutical development of therapeutic pharmaceuticals for the treatment of diseases
General Information
Serial Number | 98850670 |
Word Mark | NETHERTON NOW: BECAUSE EVERYONE DESERVES TO FEEL COMFORTABLE IN THEIR OWN SKIN |
Filing Date | Wednesday, November 13, 2024 |
Status | 686 - PUBLISHED FOR OPPOSITION |
Status Date | Tuesday, September 23, 2025 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | Tuesday, September 23, 2025 |
Trademark Statements
Goods and Services | Pharmaceutical product and therapeutic pharmaceutical product for Netherton Syndrome, and rare and orphan skin diseases |
NOT AVAILABLE | "NETHERTON" |
Goods and Services | Pharmaceutical development of therapeutic pharmaceuticals for the treatment of diseases |
Classification Information
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Wednesday, November 13, 2024 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Wednesday, November 13, 2024 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
Party Name | Quoin Pharmaceuticals, Inc. |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 03 - Corporation |
Address | Ashburn, VA 20148 |
Party Name | Quoin Pharmaceuticals, Inc. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | Ashburn, VA 20148 |
Trademark Events
Event Date | Event Description |
Wednesday, November 13, 2024 | NEW APPLICATION ENTERED |
Wednesday, May 7, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Thursday, May 8, 2025 | ASSIGNED TO EXAMINER |
Thursday, May 15, 2025 | NON-FINAL ACTION E-MAILED |
Thursday, May 15, 2025 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Thursday, May 15, 2025 | NON-FINAL ACTION WRITTEN |
Wednesday, August 13, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Wednesday, August 13, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Wednesday, August 13, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Wednesday, August 20, 2025 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Wednesday, September 17, 2025 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Tuesday, September 23, 2025 | PUBLISHED FOR OPPOSITION |
Tuesday, September 23, 2025 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |